Page 519 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 3

59. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/ personnel, frequency and ethical considerations. Heart Rhythm.
HRS 2008 guidelines for device-based therapy of cardiac 2008;5(6):907-925.
rhythm abnormalities: executive summary. Heart Rhythm. 68. Fraser JD, Gillis AM, Irwin ME, Nishimura S, Tyers GF,
2008;5(6):934-955. Philippon F. Guidelines for pacemaker follow-up in Canada:
60. Bernstein AK, Parsonnet V. Pacemaker, defibrillator, and lead a consensus statement of the Canadian Working Group on
codes. In: Ellenbogen KA, Kay GN, Lau CP, Wilkoff B, eds. Cardiac Pacing. Can J Cardiol. 2000;16(3):355-376.
Clinical Cardiac Pacing, Defibrillation, and Resynchronization 69. Chapa DW, Lee HJ, Kao CW, et al. Reducing mortality with
Therapy. 3rd ed. Philadelphia, PA: Saunders Elsevier; 2007: device therapy in heart failure patients without ventricular
279-287. arrhythmias. Am J Crit Care. 2008;17(5):443-452.
61. Bernstein AD, Daubert JC, Fletcher RD, et al. The revised 70. Tang AS, Wells GA, Talajic M, et al. Cardiac-resynchronization
NASPE/BPEG generic code for antibradycardia, adaptive-rate, therapy for mild-to-moderate heart failure. N Engl J Med.
and multisite pacing. North American Society of Pacing and 2010;363:2385-95.
Electrophysiology/British Pacing and Electrophysiology Group.
Pacing Clin Electrophysiol. 2002;25(2):260-264. 71. Gillis AM, Fast VG, Rohr S, Kleber AG. Spatial changes in trans-
membrane potential during extracellular electrical shocks in
62. Connolly SJ, Kerr CR, Gent M, et al. Effects of physiologic pac- cultured monolayers of neonatal rat ventricular myocytes. Circ
ing versus ventricular pacing on the risk of stroke and death due Res. 1996;79(4):676-690.
to cardiovascular causes. Canadian Trial of Physiologic Pacing
Investigators. N Engl J Med. 2000;342(19):1385-1391. 72. Bardy GH, Marchlinski FE, Sharma AD et al. Multicenter
comparison of truncated biphasic shocks and standard
63. Lamas GA, Lee K, Sweeney M, et al. The mode selection trial damped sine wave monophasic shocks for transthoracic ven-
(MOST) in sinus node dysfunction: design, rationale, and tricular defibrillation. Transthoracic Investigators. Circulation.
baseline characteristics of the first 1000 patients. Am Heart J. 1996;94(10):2507-2514.
2000;140(4):541-551. 73. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with
64. Gillis AM. Redefining physiologic pacing: lessons learned from an implanted defibrillator in patients with coronary disease at
recent clinical trials. Heart Rhythm. 2006;3(11):1367-1372. high risk for ventricular arrhythmia. Multicenter Automatic
65. Connolly SJ, Kerr CR, Gent M, et al. Effects of physiologic pac- Defibrillator Implantation Trial Investigators. N Engl J Med.
ing versus ventricular pacing on the risk of stroke and death due 1996;335(26):1933-1940.
to cardiovascular causes. Canadian Trial of Physiologic Pacing 74. Goldenberg I, Gillespie J, Moss AJ, et al. Long-term ben-
Investigators. N Engl J Med. 2000;342(19):1385-1391. efit of primary prevention with an implantable cardioverter-
66. Gillis AM, Philippon F, Cassidy MR, et al. Guidelines for defibrillator: an extended 8-year follow-up study of the
implantable cardioverter defibrillator follow-up in Canada: Multicenter Automatic Defibrillator Implantation Trial II.
a consensus statement of the Canadian Working Group on Circulation. 2010;122(13):1265-1271.
Cardiac Pacing. Can J Cardiol. 2003;19(1):21-37. 75. Swygman C, Wang PJ, Link MS, Homoud MK, Estes NA, III.
67. Wilkoff BL, Auricchio A, Brugada J, et al. HRS/EHRA expert Advances in implantable cardioverter defibrillators. Curr Opin
consensus on the monitoring of cardiovascular implantable elec- Cardiol. 2002;17(1):24-28.
tronic devices (CIEDs): description of techniques, indications,

Section03-O-ref.indd 3 1/20/2015 7:10:23 AM